- Home
- BRN vs BOLT Comparison
BRN vs BOLT Comparison
Compare BRN & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRN | BOLT |
|---|---|---|
| Founded | 1956 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 10.5M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BRN | BOLT |
|---|---|---|
| Price | $1.03 | $5.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 155.7K | 30.1K |
| Earning Date | 04-02-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,697,000.00 | $7,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $0.26 |
| 52 Week High | $2.28 | $7.35 |
Technical Indicators
Market Signals| Indicator | BRN | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 44.90 |
| Support Level | $0.98 | $4.27 |
| Resistance Level | $1.06 | $5.30 |
| Average True Range (ATR) | 0.07 | 0.50 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 100.00 | 44.39 |
Price Performance
Historical ComparisonAbout BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.